Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Frontiers in Immunology|September 3, 2024
Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter studyBerenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, et al.Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.Multiple Sclerosis and Related Disorders|May 23, 2020
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentinaNora Fernández Liguori, Ricardo Alonso, Amelia Alves Pinheiro, et al.Journal of the Neurological Sciences|February 7, 2018
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patientsEdgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.Multiple Sclerosis and Related Disorders|May 26, 2019
The Argentinean multiple sclerosis registry (RelevarEM): Methodological aspects and directionsJuan Ignacio Rojas, Adriana Carrá, Jorge Correale, et al.Multiple Sclerosis and Related Disorders|March 21, 2021
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAMRicardo Alonso, Berenice Silva, Orlando Garcea, et al.Multiple Sclerosis and Related Disorders|February 26, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?Geraldine G Luetic, María Laura Menichini, Carlos Vrech, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 5, 2021
Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMMatías Kohler, Eduardo Kohler, Carlos Vrech, et al.Pageof 6